Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patient-Reported Outcomes To Be Available For ‘One-Stop Shopping’ In FDA Compendium

Executive Summary

Public catalogue of assessment tools aims to foster collaborations and reduce regulatory uncertainties for drug developers trying to get clinical outcomes measurements into product labeling.

Advertisement

Related Content

FDA Launches Compendium Of Clinical Outcome Assessments With Eye On Patients
Kybella Approval Shows How To Work With FDA On Clinical Outcome Assessments
PDUFA VI: Price Tag For Patient Experience Data Validation May Go Up
FDA Oncology Office Hopes Better Advice Will Lead To More Patient-Reported Outcomes Data
Clinical Reviewers To CDER: Give Us PRO Training
COPD Patient-Reported Outcome Questionnaire Is Early Example of FDA Drug Development Tool “Approval” Process
FDA's Final PRO Guidance Grounds Policy With More Details

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS056766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel